New clinical targets of d-chiro-inositol: rationale and potential applications

Antonio Simone Laganà1,2, Simone Garzon1, Vittorio Unfer2,3

  • 1Department of Obstetrics and Gynecology, "Filippo Del Ponte" Hospital, University of Insubria , Varese, Italy.

Abstract

Insights

D-chiro-inositol (DCI) plays a crucial role in regulating steroidogenesis by mediating insulin signaling and influencing aromatase activity. DCI may offer therapeutic benefits for gynecological conditions and low testosterone without causing hypo-estrogenic states.

Area of Science:

  • Endocrinology
  • Reproductive Physiology

Background:

  • Inositols, particularly myo-inositol (MI), are vital in ovarian physiology.
  • Information on d-chiro-inositol (DCI) is limited, despite its crucial role and insulin-dependent regulation.
  • The MI:DCI ratio is tissue-specific and essential for physiological balance.

Purpose of the Study:

  • To provide an expert overview of d-chiro-inositol's (DCI) physiological role in steroidogenesis.
  • To elucidate DCI's function in mediating insulin signaling and androgen biosynthesis.
  • To explore DCI's specific modulation of aromatase enzyme activity.

Main Methods:

  • Expert opinion synthesis of existing literature.
  • Analysis of DCI's role as an intracellular insulin second messenger.
  • Review of studies on DCI's influence on aromatase gene expression.

Main Results:

  • DCI mediates insulin's intracellular signaling pathway, promoting androgen biosynthesis.
  • DCI specifically modulates aromatase activity, reducing androgen conversion to estrogens.
  • DCI influences aromatase enzyme gene expression.

Conclusions:

  • DCI administration may mimic aromatase inhibitors without inducing hypo-estrogenism.
  • DCI treatment warrants investigation for estrogen-dependent gynecological conditions.
  • DCI evaluation is recommended for managing low testosterone states in males.